Roche to Fast-track Anti-Obesity Drug Development to Compete with Rivals: FT Report
Swiss drugmaker Roche plans to accelerate the development of its anti-obesity drugs to challenge rivals like Eli Lilly (NYSE: LLY) […]
Roche to Fast-track Anti-Obesity Drug Development to Compete with Rivals: FT Report Read More »
